Daniel Schwartzlose
Private Equity Analyst at NC Advisory A/S
Profile
Daniel Schwartzlose is currently working as an Operations Director at NC Advisory A since 2022.
Prior to this, he worked at Xellia Pharmaceuticals AS as President & Xellia International from 2019 to 2022.
Mr. Schwartzlose has an MBA from the University of Technology Sydney and a graduate degree from the University of Copenhagen.
Daniel Schwartzlose active positions
| Companies | Position | Start |
|---|---|---|
| NC Advisory A/S | Private Equity Analyst | 2021-12-31 |
Former positions of Daniel Schwartzlose
| Companies | Position | End |
|---|---|---|
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Private Equity Investor | 2021-12-31 |
Training of Daniel Schwartzlose
| University of Technology Sydney | Masters Business Admin |
| University of Copenhagen | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Health Technology |
| NC Advisory A/S | Finance |
- Stock Market
- Insiders
- Daniel Schwartzlose
